Review
Copyright ©The Author(s) 2015.
World J Diabetes. Feb 15, 2015; 6(1): 136-144
Published online Feb 15, 2015. doi: 10.4239/wjd.v6.i1.136
Figure 2
Figure 2 The adjusted mean difference in HbA1c from baseline to 12 wk between placebo and the standard dose of sodium-glucose cotransporter 2 inhibitors. A: 50 mg ipragliflozin in Westerners; B: 50 mg ipragliflozin in Japanese; C: 100 mg canagliflozin in Westerners; D: 10 mg dapagliflozin in Westerners; E: 25 mg empagliflozin in Westerners.